SEC
SlamSEC
SearchBrowseEarnings

Estrella Immunopharma, Inc.

Nasdaq:ESLANasdaq:ESLAW
Biological Products, (No Diagnostic Substances)·EMERYVILLE, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

28 shown
FiledDescription
1/6/26
1.01
Material Agreement
→
6/3/25
1.01
Material Agreement
→
12/6/24
1.01
Material Agreement
→
11/7/24
1.01
AMENDMENT TO FORM 8-K
→
5/13/24
1.01
Material Agreement
→
3/7/24
1.01
Material Agreement
→
↓ 22 more
CEO
Liu Cheng
CFO
Xu Jiandong